Clinical trial

PhII One Label Non-Comparative Trial in Metastatic Hormone Refractory Prostate Cancer in Combination With Prednisolone

NCT00291005

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2004-08-01

PhasePHASE2

Study timeline

Study start (unknown)2004-08-01Date precision: month

Registry last updated2009-03-27

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Prostatic Neoplasmsunresolved

Interventions

ARD6562, DocetaxelDRUG

Sponsors & collaborators

Sanofilead sponsor

Mapped research locations

TokyoJapan1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00291005 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.